Depression and Diabetes Comorbidity Dynamics

Depression and diabetes frequently co-occur, creating a complex interplay that adversely affects patient outcomes. Individuals with diabetes are at increased risk of developing depressive symptoms, while those with depression exhibit higher rates of poor glycaemic control, diabetes complications and mortality. Behavioural factors such as reduced adherence to treatment regimens and lifestyle recommendations contribute to this bidirectional relationship, as do biological mechanisms including dysregulated inflammatory pathways and altered hypothalamic–pituitary–adrenal axis activity. The interconnection between mood regulation and metabolic homeostasis underscores the need for integrated care models that address both psychological and physiological aspects of health. Globally, the dual burden of these conditions poses major challenges for healthcare systems, highlighting the importance of early detection, multidisciplinary management and prevention strategies that target shared risk factors.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Depression and Diabetes Comorbidity Dynamics publication trend

The graph below shows the total number of articles in depression and diabetes comorbidity dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

Comorbidity: Concurrent presence of two or more medical conditions in the same individual, which can interact to worsen overall prognosis.

Glycaemic control: The regulation of blood glucose levels, most commonly assessed by measuring glycated haemoglobin (HbA1c) over time.

Mendelian randomisation: A genetic epidemiology approach that uses inherited genetic variants as proxies for modifiable exposures to assess causal relationships in observational data.

Hazard ratio: A statistical measure indicating how the risk of a particular event (such as onset of depression) changes with exposure to a variable (such as diabetes).

Macrovascular complications: Vascular disorders affecting large blood vessels, including coronary artery disease and cerebrovascular events, which are common in diabetes.

Patient Health Questionnaire (PHQ-9): A nine-item self-administered instrument used to screen for and measure the severity of depressive symptoms.

References

1. Association of type 2 diabetes according to the number of risk factors within the recommended range with incidence of major depression and clinically relevant depressive symptoms: a prospective analysis. The Lancet Healthy Longevity (2023).
2. The impact of major depressive disorder on glycaemic control in type 2 diabetes: a longitudinal cohort study using UK Biobank primary care records. BMC Medicine (2024).
3. Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses. Neuroscience & Biobehavioral Reviews (2023).